NXTC (STOCKS)
NextCure, Inc. Common Stock
$13.240000
+0.740000 (+5.92%)
Prev close: $12.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael S. Richman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.57M
- Employees
- 43
- P/E (TTM)
- -0.55
- P/B (TTM)
- 1.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-3.22 | $-4.06 | +0.8430 | +20.75% |
|
Jun 2025 (Q2)
|
$-11.29 | $-4.71 | -6.5827 | -139.84% |
|
Mar 2025 (Q1)
|
$-4.68 | $-4.90 | +0.2160 | +4.41% |
|
Dec 2024 (Q4)
|
$-4.92 | $-4.10 | -0.8196 | -19.99% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $60.31M |
| Research and Development | $47.03M |
| Other Operating Expenses | $13.29M |
| Operating Income/Loss | -$60.31M |
| Income/Loss From Continuing Operations After Tax | -$58.01M |
| Income/Loss From Continuing Operations Before Tax | -$58.01M |
| Net Income/Loss | -$58.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$58.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$58.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.02 |
| Diluted Earnings Per Share | $2.02 |
| Basic Average Shares | 58,692,949 |
| Diluted Average Shares | 58,692,949 |
| Assets | $39.61M |
| Current Assets | $32.64M |
| Noncurrent Assets | $6.97M |
| Fixed Assets | $3.64M |
| Other Non-current Assets | $3.34M |
| Liabilities | $15.97M |
| Current Liabilities | $11.00M |
| Accounts Payable | $2.39M |
| Other Current Liabilities | $8.60M |
| Noncurrent Liabilities | $4.97M |
| Equity | $23.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $23.65M |
| Liabilities And Equity | $39.61M |
| Net Cash Flow From Operating Activities | -$48.94M |
| Net Cash Flow From Operating Activities, Continuing | -$48.94M |
| Net Cash Flow From Investing Activities | $26.51M |
| Net Cash Flow From Investing Activities, Continuing | $26.51M |
| Net Cash Flow From Financing Activities | $2.06M |
| Net Cash Flow From Financing Activities, Continuing | $2.06M |
| Net Cash Flow | -$20.38M |
| Net Cash Flow, Continuing | -$20.38M |
| Comprehensive Income/Loss | -$58.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$58.07M |
| Other Comprehensive Income/Loss | -$8.67M |